We could not find any results for:
Make sure your spelling is correct or try broadening your search.
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Dec. 6, 2023 VANCOUVER, BC, Dec. 6, 2023 /CNW/ -TSX VENTURE COMPANIES BULLETIN V2023-0173 BULLETIN TYPE: Cease...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - PSYB Canada NewsWire VANCOUVER, BC, le 6 déc. 2023 VANCOUVER, BC, le 6 déc. 2023...
Canadian Investment Regulatory Organization Trading Halt - PSYB Canada NewsWire VANCOUVER, BC, Dec. 6, 2023 VANCOUVER, BC, Dec. 6, 2023 /CNW/ - The following issues have been halted by...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - PSYB Canada NewsWire VANCOUVER, BC, le 27 nov. 2023 VANCOUVER, BC, le 27 nov. 2023...
Canadian Investment Regulatory Organization Trading Halt - PSYB Canada NewsWire VANCOUVER, BC, Nov. 27, 2023 VANCOUVER, BC, Nov. 27, 2023 /CNW/ - The following issues have been halted by...
PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert Toad as it Files Three New Provisional Patent Applications, Including Intellectual Property Protection for the...
PsyBio Therapeutics Files Four U.S. Patent Cooperation Treaty (PCT) Patent Applications Further Expanding Its Patent Portfolio Canada NewsWire OXFORD, OH and DENVER, Dec. 6, 2022 PsyBio continues...
PsyBio Therapeutics Announces Non-Brokered Private Placement Financing Canada NewsWire OXFORD, Ohio and DENVER, Dec. 1, 2022 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR...
PsyBio Therapeutics Reports Third Quarter 2022 Financial Results Canada NewsWire OXFORD, Ohio and DENVER, Nov. 29, 2022 OXFORD, Ohio and DENVER, Nov. 29, 2022 /CNW/ – PsyBio Therapeutics Corp...
PsyBio Therapeutics Reaches Agreement to Conduct Initial Psilocybin Clinical Trial Canada NewsWire OXFORD, OH and DENVER, CO, Oct. 11, 2022 PsyBio continues towards understanding psycho-targeted...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions